{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:16:18Z","timestamp":1725840978778},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","interventional.theclinics.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.iccl.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T11:24:48Z","timestamp":1723548288000},"page":"561-575","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism Interventions"],"prefix":"10.1016","volume":"13","author":[{"given":"\u00c1lvaro","family":"Dubois-Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iccl.2024.07.004_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.004_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jtcvs.2017.07.074","article-title":"Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013","volume":"155","author":"Lee","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"Suppl I","key":"10.1016\/j.iccl.2024.07.004_bib3","doi-asserted-by":"crossref","first-page":"I16","DOI":"10.1093\/eurheartj\/suz223","article-title":"Rationale for catheter-based therapies in acute pulmonary embolism","volume":"21","author":"de Winter","year":"2019","journal-title":"Eur Hear J Suppl J Eur Soc Cardiol"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.004_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/s-0043-1772840","article-title":"Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up","volume":"49","author":"Fulton","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.004_bib5","doi-asserted-by":"crossref","first-page":"2000538","DOI":"10.1183\/13993003.00538-2020","article-title":"Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi","volume":"56","author":"Bikdeli","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib6","doi-asserted-by":"crossref","first-page":"1701775","DOI":"10.1183\/13993003.01775-2017","article-title":"Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials","volume":"51","author":"Barco","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iccl.2024.07.004_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2022.05.011","article-title":"Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study","volume":"251","author":"Klok","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2024.07.004_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.861307","article-title":"Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients","volume":"9","author":"Pietrasik","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.004_bib9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jamacardio.2022.3591","article-title":"Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial","volume":"7","author":"Sadeghipour","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.004_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.202212-2234VP","article-title":"Revised Paradigm for Acute Pulmonary Embolism Prognostication and Treatment","volume":"208","author":"Jim\u00e9nez","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iccl.2024.07.004_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ahj.2023.09.002","article-title":"Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study","volume":"266","author":"Gonsalves","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2024.07.004_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjcard.2022.06.004","article-title":"Meta-Analysis Comparing Catheter-Directed Thrombolysis Versus Systemic Anticoagulation Alone for Submassive Pulmonary Embolism","volume":"178","author":"Ismayl","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2024.07.004_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.resuscitation.2021.10.007","article-title":"Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolism","volume":"170","author":"Hobohm","year":"2022","journal-title":"Resuscitation"},{"key":"10.1016\/j.iccl.2024.07.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.resuscitation.2023.109940","article-title":"Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism. An analysis of the ELSO database","volume":"191","author":"Rivers","year":"2023","journal-title":"Resuscitation"},{"issue":"7\u20138","key":"10.1016\/j.iccl.2024.07.004_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1345\/aph.1P088","article-title":"Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients","volume":"44","author":"Riney","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MBC.0000000000001175","article-title":"Factors associated with bleeding after ultrasound-assisted catheter-directed thrombolysis for the treatment of pulmonary embolism","volume":"34","author":"Shald","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1358863X16676355","article-title":"Risk factors for major bleeding in the SEATTLE II trial","volume":"22","author":"Sadiq","year":"2017","journal-title":"Vasc Med"},{"issue":"24","key":"10.1016\/j.iccl.2024.07.004_bib18","doi-asserted-by":"crossref","first-page":"E833","DOI":"10.1503\/cmaj.220960","article-title":"Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis","volume":"195","author":"Planer","year":"2023","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"18","key":"10.1016\/j.iccl.2024.07.004_bib19","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2020.05.028","article-title":"Advanced Management of Intermediate- and High-Risk Pulmonary Embolism: JACC Focus Seminar","volume":"76","author":"Piazza","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.iccl.2024.07.004_bib20","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1161\/CIR.0000000000000707","article-title":"Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association","volume":"140","author":"Giri","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.004_bib21","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.iccl.2024.07.004_bib22","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2024.07.004_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619853037","article-title":"Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium","volume":"25","author":"Rivera-Lebron","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.004_bib24","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.4244\/EIJ-D-22-00246","article-title":"Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions","volume":"18","author":"Pruszczyk","year":"2022","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.iccl.2024.07.004_bib25","article-title":"Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism","volume":"10","author":"Bikdeli","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.iccl.2024.07.004_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231190963","article-title":"Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin","volume":"11","author":"Nguyen","year":"2023","journal-title":"SAGE open Med"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.004_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ajh.25565","article-title":"Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin time","volume":"94","author":"Coons","year":"2019","journal-title":"Am J Hematol"},{"issue":"7\u20138","key":"10.1016\/j.iccl.2024.07.004_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1345\/aph.1Q161","article-title":"Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion","volume":"45","author":"Guervil","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.004_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0897190010362172","article-title":"The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy","volume":"23","author":"Rosenberg","year":"2010","journal-title":"J\u00a0Pharm Pract"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.004_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/j.1875-9114.2011.01049.x","article-title":"Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin","volume":"32","author":"Vandiver","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.iccl.2024.07.004_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2021.10.010","article-title":"Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin: A systematic review and meta-analysis","volume":"208","author":"Swayngim","year":"2021","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11239-015-1315-2","article-title":"Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism","volume":"41","author":"Smythe","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.004_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin Resistance - Clinical Perspectives and Management Strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.004_bib34","first-page":"CD001100","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism","volume":"2","author":"Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.iccl.2024.07.004_bib35","first-page":"69","article-title":"Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs","volume":"30","author":"Walenga","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.004_bib36","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1345\/aph.1M615","article-title":"Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: a cohort study in the context of a quality improvement initiative","volume":"44","author":"Cossette","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.004_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/acem.13872","article-title":"Analysis of Partial Thromboplastin Times in Patients With Pulmonary Embolism During the First 48 Hours of Anticoagulation With Unfractionated Heparin","volume":"27","author":"Prucnal","year":"2020","journal-title":"Acad Emerg Med"},{"issue":"10","key":"10.1016\/j.iccl.2024.07.004_bib38","doi-asserted-by":"crossref","first-page":"e013406","DOI":"10.1161\/CIRCINTERVENTIONS.123.013406","article-title":"Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study","volume":"16","author":"Silver","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.004_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jcin.2020.09.053","article-title":"Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial","volume":"14","author":"Sista","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.iccl.2024.07.004_bib40","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4244\/EIJ-D-22-00732","article-title":"Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism","volume":"18","author":"Toma","year":"2023","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.004_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jcin.2018.12.022","article-title":"A\u00a0Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study","volume":"12","author":"Tu","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib42","first-page":"101192","article-title":"Modern treatment of pulmonary embolism (USCDT Versus MT): results from a Real-World, Big Data Analysis (REAL-PE)","volume":"3","author":"Monteleone","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.004_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.iccl.2024.07.004_bib44","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A\u00a0Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study","volume":"8","author":"Piazza","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.iccl.2024.07.004_bib45","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jcin.2018.04.008","article-title":"A\u00a0Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial","volume":"11","author":"Tapson","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.004_bib46","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jcin.2021.04.049","article-title":"Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism: The SUNSET sPE Trial","volume":"14","author":"Avgerinos","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.iccl.2024.07.004_bib47","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jcin.2022.09.011","article-title":"Pharmacomechanical Catheter-Directed Thrombolysis With the Bashir Endovascular Catheter for Acute Pulmonary Embolism: The RESCUE Study","volume":"15","author":"Bashir","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.004_bib48","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.4244\/EIJ-D-21-01080","article-title":"A\u00a0pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism","volume":"18","author":"Kroupa","year":"2022","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.004_bib49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jvir.2016.09.012","article-title":"Percutaneous Pulmonary Embolectomy Using the FlowTriever Retrieval\/Aspiration System","volume":"28","author":"Chauhan","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00270-022-03266-0","article-title":"Percutaneous Large-Bore Pulmonary Thrombectomy with the FlowTriever Device: Initial Experience in Intermediate-High and High-Risk Patients","volume":"46","author":"Luedemann","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.004_bib51","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ehjacc\/zuad066","article-title":"Catheter-directed mechanical aspiration thrombectomy in a real-world pulmonary embolism population: a multicenter registry","volume":"12","author":"S\u0142awek-Szmyt","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.004_bib52","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jvir.2023.05.011","article-title":"Percutaneous Mechanical Thrombectomy as Primary Therapy for High-Risk Pulmonary Embolism in Patients with Absolute Contraindications to Anticoagulation","volume":"34","author":"Zaazoue","year":"2023","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.iccl.2024.07.004_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2023.10.001","article-title":"Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy","volume":"267","author":"Zhang","year":"2024","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.iccl.2024.07.004_bib54","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.21037\/jtd.2018.07.87","article-title":"Surgical embolectomy for acute massive pulmonary embolism: state of the art","volume":"10","author":"Iaccarino","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.004_bib55","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.athoracsur.2017.09.061","article-title":"The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass","volume":"105","author":"Shore-Lesserson","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.004_bib56","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1161\/CIR.0000000000001117","article-title":"Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Association","volume":"147","author":"Goldberg","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.004_bib57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bja.2019.09.012","article-title":"2019 EACTS\/EACTA\/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"123","author":"Kunst","year":"2019","journal-title":"Br J Anaesth"},{"issue":"11","key":"10.1016\/j.iccl.2024.07.004_bib58","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/jth.14276","article-title":"Antithrombotic therapy management of adult and pediatric cardiac surgery patients","volume":"16","author":"Baumann","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.004_bib59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0267659112468014","article-title":"ECMO cannula review","volume":"28","author":"Kohler","year":"2013","journal-title":"Perfusion"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.004_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jamcollsurg.2018.08.183","article-title":"American College of Surgeons\u2019 Guidelines for the Perioperative Management of Antithrombotic Medication","volume":"227","author":"Hornor","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2 Suppl","key":"10.1016\/j.iccl.2024.07.004_bib61","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.004_bib62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jtha.2022.11.014","article-title":"Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and","volume":"21","author":"Helms","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.004_bib63","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/medicina58121783","article-title":"Anticoagulation Management during Extracorporeal Membrane Oxygenation-A Mini-Review","volume":"58","author":"Bur\u0161a","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-020-2726-9","article-title":"Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO","volume":"24","author":"Chlebowski","year":"2020","journal-title":"Crit Care"},{"issue":"18","key":"10.1016\/j.iccl.2024.07.004_bib65","first-page":"6067","article-title":"Update on Anticoagulation Strategies in Patients with ECMO-A Narrative Review","volume":"12","author":"\u0160olt\u00e9s","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.004_bib66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO Adult and Pediatric Anticoagulation Guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.004_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0267659120952982","article-title":"Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"36","author":"Willems","year":"2021","journal-title":"Perfusion"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.004_bib68","doi-asserted-by":"crossref","first-page":"101848","DOI":"10.1016\/j.jvsv.2024.101848","article-title":"Treatment of acute pulmonary embolism after catheter-directed thrombolysis with dabigatran vs warfarin: results of a multicenter randomized RE-SPIRE trial","volume":"12","author":"Gostev","year":"2024","journal-title":"J\u00a0Vasc Surgery Venous Lymphat Disord"},{"issue":"19","key":"10.1016\/j.iccl.2024.07.004_bib69","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.004_bib70","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jacc.2023.10.038","article-title":"When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review","volume":"83","author":"Bejjani","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2024.07.004_bib71","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.iccl.2024.07.004_bib72","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.iccl.2024.07.004_bib73","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.iccl.2024.07.004_bib74","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.004_bib75","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.iccl.2024.07.004_bib76","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.iccl.2024.07.004_bib78","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for Prevention of Venous Thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.004_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12509","article-title":"Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition","volume":"5","author":"Mavromanoli","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.004_bib80","first-page":"69","article-title":"Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors","volume":"48","author":"Bentounes","year":"2023","journal-title":"J\u00a0Med Vasc"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.004_bib81","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/a-2043-0346","article-title":"Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis","volume":"123","author":"Galli","year":"2023","journal-title":"Thromb Haemost"},{"issue":"22","key":"10.1016\/j.iccl.2024.07.004_bib82","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.004_bib83","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.004_bib84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ejcts\/ezx325","article-title":"2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery","volume":"53","author":"Pagano","year":"2018","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.004_bib85","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.athoracsur.2021.03.033","article-title":"STS\/SCA\/AmSECT\/SABM Update to the Clinical Practice Guidelines on Patient Blood Management","volume":"112","author":"Tibi","year":"2021","journal-title":"Ann Thorac Surg"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:56:24Z","timestamp":1725836184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745824000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2211745824000695"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.004","relation":{},"ISSN":["2211-7458"],"issn-type":[{"type":"print","value":"2211-7458"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism Interventions","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}